News for Healthier Living

New Moffitt Study Offers Clues to Why TIL Immunotherapy Works for Some Melanoma Patients but Not Others

For some people with advanced melanoma, tumor-infiltrating lymphocyte (TIL) therapy has produced remarkable responses, even after other treatments have stopped working. Yet it doesn't succeed for everyone. Researchers have long wondered why some patients experience dramatic, long-lasting responses while others receive little benefit from the same therapy.

August 12, 2026


August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026